drug

Pyridoxal 5'-Phosphate

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Medicure
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
small molecule

Indications

Trials

1
Safety and Efficacy of Pyridoxal 5' -Phosphate in the Treatment of Tardive Dyskinesia
NCT00917293Phase 2Terminated

KOLs & investigators

1
Gary Remington, MD PhD FRCPCKOL score 12

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Medicure
company
trial
Safety and Efficacy of Pyridoxal 5' -Phosphate in the Treatment of Tardive Dyskinesia
PHASE2
trial
indication
Schizophrenia
indication
Tardive Dyskinesia
indication
Tardive Dyskinesia
indication
KOL
Gary Remington, MD PhD FRCPC
KOL score 12
person